Shannon Medical Ctr-Dev Office is categorized under Clinics in San Angelo, TX .
Shannon Medical Ctr-Dev Office was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Suzi Reynolds, Administrator at the company’s single location by writing to 127 East Beauregard Avenue, San Angelo, Texas TX 76903 or by phoning (325) 657-8370. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shannon Medical Ctr-Dev Office |
| Contact Person: | Suzi Reynolds, Administrator |
| Address: | 127 East Beauregard Avenue, San Angelo, Texas 76903 |
| Phone Number: | (325) 657-8370 |
| Website Address: | shannonhealth.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Shannon Medical Ctr-Dev Office was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Suzi Reynolds, Administrator for inquiries that concern Shannon Medical Ctr-Dev Office by calling the company number (325) 657-8370, as your correspondence is most welcome. Additionally, the physical location of the single location of Shannon Medical Ctr-Dev Office can be found at the coordinates 31.46346,-100.43412 as well as the street address 127 East Beauregard Avenue in San Angelo, Texas 76903.
For its online presence, you may visit Shannon Medical Ctr-Dev Office’s website at shannonhealth.com and engage with its social media outlets through on Twitter and on Facebook.